Discussion
Kaposi's sarcoma, a relatively indolent disease, has become increasingly rare with improved treatment and screening for HIV/AIDS. It now occurs at a rate of about 6 cases per million people each year. 1 The disease is caused by infection with the human herpes virus 8 (HHV-8). The classification of the disease is divided into 4 groups: Classic, originally described by Dr. Moritz Kaposi in 1872, endemic (occurring mainly in sub-Sahara Africa), iatrogenic, and AIDSassociated. Due to his presentation and prevalence of Pneumocystis jiroveci, this patient was initially started on treatment for Pneumocystis jirovecii in addition to anti-retroviral therapy (ART). The treatment, however, did not improve his symptoms, thus warranting bronchoscopy. The primary treatment of Kaposi's sarcoma is treatment of HIV infection using ART. Oral lesions can be treated with vinblastine 2 ; therapy for individual lesions can be initiated with local management such as radiation. 3 There is currently no consensus on systemic treatment; however, in individuals with progressive or severe Kaposi's sarcoma, combination of highly active anti-retroviral therapy (HAART) and chemotherapy (liposomal doxorubicin, liposomal daunorubicin, or paclitaxel) reduced the disease progression to a greater extent than HAART alone. 4 Paradoxically, initiation of ART or HAART for a patient who has already been diagnosed with Kaposi's sarcoma can lead to immune reconstitution inflammatory syndrome (IRIS) and subsequent Kaposi's sarcoma exacerbation leading to significant increase in morbidity and mortality. 5, 6, 7 Involvement of visceral organs is infrequent, and therefore image staging is not routinely completed. "In the multivariate analysis, staging (T1), CD4 cell count (<200 cells/µl), [and] positive HHV8 DNA in plasma, at the time of diagnosis, predict evolution towards death or the need of chemotherapy." 8 Kaposi's sarcoma has also been found to present in the lungs 9 , which is a possible manifestation for this patient. Additionally, the patient's symptoms of SOB and fatigue have appeared in other patients with pulmonary Kaposi's sarcoma. 
